UA41280C2 - OXAZOLIDINONES, THEIR SALTS, THE METHOD OF THEIR PREPARATION, THE PHARMACEUTICAL PREPARATION AND THE METHOD OF OBTAINING IT - Google Patents
OXAZOLIDINONES, THEIR SALTS, THE METHOD OF THEIR PREPARATION, THE PHARMACEUTICAL PREPARATION AND THE METHOD OF OBTAINING ITInfo
- Publication number
- UA41280C2 UA41280C2 UA94005166A UA94005166A UA41280C2 UA 41280 C2 UA41280 C2 UA 41280C2 UA 94005166 A UA94005166 A UA 94005166A UA 94005166 A UA94005166 A UA 94005166A UA 41280 C2 UA41280 C2 UA 41280C2
- Authority
- UA
- Ukraine
- Prior art keywords
- preparation
- salts
- oxazolidinones
- obtaining
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 108010012088 Fibrinogen Receptors Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Новые соединения, в качестве антагонистов адгезивных рецепторов, способ их получения, фармкомпозициях на их основе и способ ее получения Новые соединения формулы I где R1, Х и У имеют значения, данные в п.1 формулы, а также их соли, препятствуют соединению фибриногенов с фибриногенными рецепторами и могут использоваться для лечения тромбозов, апоплексии, инфаркта миокарда, воспалений, артериосклероза, остеопороза, а также опухолей.New compounds, as antagonists of adhesive receptors, a method for their preparation, pharmaceutical compositions based on them and a method for its preparation New compounds of formula I where R1, X and Y have the meanings given in claim 1 of the formula, as well as their salts, prevent the combination of fibrinogens with fibrinogen receptors and can be used to treat thrombosis, apoplexy, myocardial infarction, inflammation, arteriosclerosis, osteoporosis, and tumors.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4314378 | 1993-05-01 | ||
| DE4405633A DE4405633A1 (en) | 1993-05-01 | 1994-02-22 | Adhesion receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA41280C2 true UA41280C2 (en) | 2001-09-17 |
Family
ID=6486893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA94005166A UA41280C2 (en) | 1993-05-01 | 1994-04-07 | OXAZOLIDINONES, THEIR SALTS, THE METHOD OF THEIR PREPARATION, THE PHARMACEUTICAL PREPARATION AND THE METHOD OF OBTAINING IT |
Country Status (4)
| Country | Link |
|---|---|
| DE (2) | DE4405633A1 (en) |
| TW (1) | TW336224B (en) |
| UA (1) | UA41280C2 (en) |
| ZA (1) | ZA942973B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4429461A1 (en) * | 1994-08-19 | 1996-02-22 | Merck Patent Gmbh | Adhesion receptor antagonists |
| DE4439846A1 (en) * | 1994-11-08 | 1996-05-09 | Merck Patent Gmbh | Adhesion receptor antagonists |
-
1994
- 1994-02-22 DE DE4405633A patent/DE4405633A1/en not_active Withdrawn
- 1994-04-07 UA UA94005166A patent/UA41280C2/en unknown
- 1994-04-19 DE DE59408441T patent/DE59408441D1/en not_active Expired - Fee Related
- 1994-04-28 TW TW083103856A patent/TW336224B/en active
- 1994-04-29 ZA ZA942973A patent/ZA942973B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA942973B (en) | 1995-01-18 |
| DE4405633A1 (en) | 1994-11-03 |
| TW336224B (en) | 1998-07-11 |
| DE59408441D1 (en) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94015184A (en) | NEW CONNECTIONS AS ANTAGONISTS OF ADHESIVE RECEPTORS, METHOD OF THEIR PREPARATION, PHARMOCOMPOSITION ON THEIR BASIS AND METHOD OF IT | |
| DK0623615T3 (en) | Adhesion receptor antagonists | |
| RU94034124A (en) | Oxazolidinone derivatives, process for preparing thereof, pharmaceutical composition and process for preparing thereof | |
| FI865269A0 (en) | HATEROCYCLISKA FOERENINGAR KVAEVEHALTIGA. | |
| EA199700186A1 (en) | NEW DIPEPTID AMIDINES USED AS THROMBIN INHIBITORS | |
| AR007160A1 (en) | ADHESION RECEPTOR ANTAGONIST COMPOUNDS, PROCEDURE FOR PREPARING THESE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| GEP20033114B (en) | Biphenyl Sulfonamides as Dual Angiotensin Endothelin Receptor Antagonists, Method for Their Production and Pharmaceutical Compositions Containing the Same | |
| EA200000920A1 (en) | DERIVATIVES OF BICYCLIC HYDROXAMIC ACIDS | |
| RU94002323A (en) | DERIVATIVES OF PIPERAZINS, METHOD OF THEIR RECEPTION, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PRODUCTION AND USE | |
| EA200200253A1 (en) | INHIBITORS OF CELLULAR ADHESION | |
| EA200100139A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 2-CHINOLONES | |
| ATE204570T1 (en) | PIPERAZINE DERIVATIVES | |
| AR009070A1 (en) | COMPOUNDS DERIVED FROM HETERO-CYCLIC AMIDINES OF FIVE MEMBERS, THEIR USE AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PRODUCTION OF THEM. | |
| BG103558A (en) | Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| AR002245A1 (en) | ANTAGONISTS OF THE ADHESION RECEPTOR, PROCEDURE TO PREPARE THEM, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE MEDICINES. | |
| ES2118708T3 (en) | COMPOSITIONS OF PIPERIDINE AND ITS PREPARATION AND USE. | |
| EA200100517A1 (en) | ANTAGONISTS 5HT1 FOR ANTIDEPRESSANT THERAPY | |
| UA41280C2 (en) | OXAZOLIDINONES, THEIR SALTS, THE METHOD OF THEIR PREPARATION, THE PHARMACEUTICAL PREPARATION AND THE METHOD OF OBTAINING IT | |
| EA199900216A1 (en) | Anti-thrombotic azocycloalkylalkanoyl peptides and pseudopeptides | |
| EA199700223A1 (en) | BICYCLIC ANTAGONISTS OF TACHIKININS, THEIR RECEIVING AND APPLICATION IN THE PHARMACEUTICAL COMPOSITION | |
| RU94036762A (en) | Heteroarylpiperidines, method of their synthesis, intermediate compounds at synthesis and pharmaceutical composition | |
| EA200500290A1 (en) | METHOD AND CONNECTIONS STIMULATING THE PROCESSES OF THE HEALING AND MITIGATION OF INFLAMMATION | |
| NO20002154L (en) | Novel heterocyclic substituted alpha hydroxycarboxylic acid derivatives | |
| RU93033480A (en) | CYCLIC ADHESION INHIBITORS | |
| ES2010524A6 (en) | PROCEDURE FOR OBTAINING A PHARMACEUTICAL COMPOSITION BASED ON CALCIUM ANTAGONISTS USEFUL IN THE TREATMENT OF HYPERTENSION AND CONGESTIVE CARDIAC FAILURE. |